Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Muscle xenografts reproduce key molecular features of facioscapulohumeral muscular dystrophy.

Mueller AL, O'Neill A, Jones TI, Llach A, Rojas LA, Sakellariou P, Stadler G, Wright WE, Eyerman D, Jones PL, Bloch RJ.

Exp Neurol. 2019 Oct;320:113011. doi: 10.1016/j.expneurol.2019.113011. Epub 2019 Jul 12.

PMID:
31306642
2.

Identification of Epigenetic Regulators of DUX4-fl for Targeted Therapy of Facioscapulohumeral Muscular Dystrophy.

Himeda CL, Jones TI, Virbasius CM, Zhu LJ, Green MR, Jones PL.

Mol Ther. 2018 Jul 5;26(7):1797-1807. doi: 10.1016/j.ymthe.2018.04.019. Epub 2018 Apr 26.

3.

Corrigendum: SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome.

Shaw ND, Brand H, Kupchinsky ZA, Bengani H, Plummer L, Jones TI, Erdin S, Williamson KA, Rainger J, Stortchevoi A, Samocha K, Currall BB, Dunican DS, Collins RL, Willer JR, Lek A, Lek M, Nassan M, Pereira S, Kammin T, Lucente D, Silva A, Seabra CM, Chiang C, An Y, Ansari M, Rainger JK, Joss S, Smith JC, Lippincott MF, Singh SS, Patel N, Jing JW, Law JR, Ferraro N, Verloes A, Rauch A, Steindl K, Zweier M, Scheer I, Sato D, Okamoto N, Jacobsen C, Tryggestad J, Chernausek S, Schimmenti LA, Brasseur B, Cesaretti C, García-Ortiz JE, Buitrago TP, Silva OP, Hoffman JD, Mühlbauer W, Ruprecht KW, Loeys BL, Shino M, Kaindl AM, Cho CH, Morton CC, Meehan RR, van Heyningen V, Liao EC, Balasubramanian R, Hall JE, Seminara SB, Macarthur D, Moore SA, Yoshiura KI, Gusella JF, Marsh JA, Graham JM Jr, Lin AE, Katsanis N, Jones PL, Crowley WF Jr, Davis EE, FitzPatrick DR, Talkowski ME.

Nat Genet. 2017 May 26;49(6):969. doi: 10.1038/ng0617-969c. No abstract available.

PMID:
28546579
4.

Large family cohorts of lymphoblastoid cells provide a new cellular model for investigating facioscapulohumeral muscular dystrophy.

Jones TI, Himeda CL, Perez DP, Jones PL.

Neuromuscul Disord. 2017 Mar;27(3):221-238. doi: 10.1016/j.nmd.2016.12.007. Epub 2016 Dec 23.

5.

SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome.

Shaw ND, Brand H, Kupchinsky ZA, Bengani H, Plummer L, Jones TI, Erdin S, Williamson KA, Rainger J, Stortchevoi A, Samocha K, Currall BB, Dunican DS, Collins RL, Willer JR, Lek A, Lek M, Nassan M, Pereira S, Kammin T, Lucente D, Silva A, Seabra CM, Chiang C, An Y, Ansari M, Rainger JK, Joss S, Smith JC, Lippincott MF, Singh SS, Patel N, Jing JW, Law JR, Ferraro N, Verloes A, Rauch A, Steindl K, Zweier M, Scheer I, Sato D, Okamoto N, Jacobsen C, Tryggestad J, Chernausek S, Schimmenti LA, Brasseur B, Cesaretti C, García-Ortiz JE, Buitrago TP, Silva OP, Hoffman JD, Mühlbauer W, Ruprecht KW, Loeys BL, Shino M, Kaindl AM, Cho CH, Morton CC, Meehan RR, van Heyningen V, Liao EC, Balasubramanian R, Hall JE, Seminara SB, Macarthur D, Moore SA, Yoshiura KI, Gusella JF, Marsh JA, Graham JM Jr, Lin AE, Katsanis N, Jones PL, Crowley WF Jr, Davis EE, FitzPatrick DR, Talkowski ME.

Nat Genet. 2017 Feb;49(2):238-248. doi: 10.1038/ng.3743. Epub 2017 Jan 9. Erratum in: Nat Genet. 2017 May 26;49(6):969.

6.

Transgenic Drosophila for Investigating DUX4 and FRG1, Two Genes Associated with Facioscapulohumeral Muscular Dystrophy (FSHD).

Jones TI, Parilla M, Jones PL.

PLoS One. 2016 Mar 4;11(3):e0150938. doi: 10.1371/journal.pone.0150938. eCollection 2016.

7.

Scalpel or Straitjacket: CRISPR/Cas9 Approaches for Muscular Dystrophies.

Himeda CL, Jones TI, Jones PL.

Trends Pharmacol Sci. 2016 Apr;37(4):249-251. doi: 10.1016/j.tips.2016.02.001. Epub 2016 Feb 22.

8.

CRISPR/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy.

Himeda CL, Jones TI, Jones PL.

Mol Ther. 2016 Mar;24(3):527-35. doi: 10.1038/mt.2015.200. Epub 2015 Nov 3.

9.

Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy.

Jones TI, King OD, Himeda CL, Homma S, Chen JC, Beermann ML, Yan C, Emerson CP Jr, Miller JB, Wagner KR, Jones PL.

Clin Epigenetics. 2015 Mar 29;7:37. doi: 10.1186/s13148-015-0072-6. eCollection 2015.

10.

Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing.

Jones TI, Yan C, Sapp PC, McKenna-Yasek D, Kang PB, Quinn C, Salameh JS, King OD, Jones PL.

Clin Epigenetics. 2014 Oct 29;6(1):23. doi: 10.1186/1868-7083-6-23. eCollection 2014.

11.

Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and disease.

Himeda CL, Jones TI, Jones PL.

Antioxid Redox Signal. 2015 Jun 1;22(16):1463-82. doi: 10.1089/ars.2014.6090. Epub 2014 Dec 4. Review.

12.

Myogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene.

Himeda CL, Debarnot C, Homma S, Beermann ML, Miller JB, Jones PL, Jones TI.

Mol Cell Biol. 2014 Jun;34(11):1942-55. doi: 10.1128/MCB.00149-14. Epub 2014 Mar 17.

13.

Human skeletal muscle xenograft as a new preclinical model for muscle disorders.

Zhang Y, King OD, Rahimov F, Jones TI, Ward CW, Kerr JP, Liu N, Emerson CP Jr, Kunkel LM, Partridge TA, Wagner KR.

Hum Mol Genet. 2014 Jun 15;23(12):3180-8. doi: 10.1093/hmg/ddu028. Epub 2014 Jan 22.

14.

Exome sequencing identifies a novel SMCHD1 mutation in facioscapulohumeral muscular dystrophy 2.

Mitsuhashi S, Boyden SE, Estrella EA, Jones TI, Rahimov F, Yu TW, Darras BT, Amato AA, Folkerth RD, Jones PL, Kunkel LM, Kang PB.

Neuromuscul Disord. 2013 Dec;23(12):975-80. doi: 10.1016/j.nmd.2013.08.009. Epub 2013 Aug 31.

15.

Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis.

Jones TI, Chen JC, Rahimov F, Homma S, Arashiro P, Beermann ML, King OD, Miller JB, Kunkel LM, Emerson CP Jr, Wagner KR, Jones PL.

Hum Mol Genet. 2012 Oct 15;21(20):4419-30. Epub 2012 Jul 13.

16.

C. elegans PAT-9 is a nuclear zinc finger protein critical for the assembly of muscle attachments.

Liu Q, Jones TI, Bachmann RA, Meghpara M, Rogowski L, Williams BD, Jones PL.

Cell Biosci. 2012 May 22;2(1):18. doi: 10.1186/2045-3701-2-18.

17.

Facioscapulohumeral muscular dystrophy region gene 1 is a dynamic RNA-associated and actin-bundling protein.

Sun CY, van Koningsbruggen S, Long SW, Straasheijm K, Klooster R, Jones TI, Bellini M, Levesque L, Brieher WM, van der Maarel SM, Jones PL.

J Mol Biol. 2011 Aug 12;411(2):397-416. doi: 10.1016/j.jmb.2011.06.014. Epub 2011 Jun 15.

18.

The nucleoporin Seh1 forms a complex with Mio and serves an essential tissue-specific function in Drosophila oogenesis.

Senger S, Csokmay J, Akbar T, Jones TI, Sengupta P, Lilly MA.

Development. 2011 May;138(10):2133-42. doi: 10.1242/dev.057372. Erratum in: Development. 2011 Jun;138(12):2631. Tanveer, Akbar [corrected to Akbar, Tanveer].

19.

Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1) is a dynamic nuclear and sarcomeric protein.

Hanel ML, Sun CY, Jones TI, Long SW, Zanotti S, Milner D, Jones PL.

Differentiation. 2011 Feb;81(2):107-18. doi: 10.1016/j.diff.2010.09.185.

20.

Facioscapulohumeral muscular dystrophy region gene-1 (FRG-1) is an actin-bundling protein associated with muscle-attachment sites.

Liu Q, Jones TI, Tang VW, Brieher WM, Jones PL.

J Cell Sci. 2010 Apr 1;123(Pt 7):1116-23. doi: 10.1242/jcs.058958. Epub 2010 Mar 9.

21.

Some aspects of vitamin E related to humans and breast cancer prevention.

Dimitrov NV, Pan RQ, Bauer J, Jones TI.

Adv Exp Med Biol. 1994;364:119-27.

PMID:
7725956
22.

Pleural blast crisis in chronic myelogenous leukemia.

Jones TI.

Am J Hematol. 1993 Sep;44(1):75-6. No abstract available.

PMID:
8342572
23.

Management of Vipera berus adder bite.

Jones TI, Clegg W.

Practitioner. 1985 Nov;229(1409):956-8. No abstract available.

PMID:
4070161
24.

The sick doctor.

Jones TI.

Br Med J. 1980 Aug 30;281(6240):623. No abstract available.

25.

Activity and recurrent hernia.

Jones TI.

Br Med J. 1977 Sep 10;2(6088):707. No abstract available.

26.

A comparative study of inguinal herniorrhaphy.

Jones TI.

Am Surg. 1975 Jan;41(1):20-7.

PMID:
803047
27.

The presence of protein bound intermediates in the biosynthesis of gramicidin S.

Jones TI, Vaage O, Zimmer TL, Frøholm LO, Laland SG.

FEBS Lett. 1968 Oct;1(5):346-348. No abstract available.

28.

Clinical gastric "freezing".

Barner HB, Collins CH, Jones TI, Garlick TB.

Am J Dig Dis. 1966 Aug;11(8):625-9. No abstract available.

PMID:
5943768
29.

MORPHOLOGY OF HUMAN STOMACH AFTER THERAPEUTIC FREEZING.

BARNER HB, COLLINS CH, JONES TI, GARLICK TB.

Arch Surg. 1965 Mar;90:358-62. No abstract available.

PMID:
14247409
30.

TEMPORARY IMPAIRMENT OF VITAMIN B 12 ABSORPTION. ANOTHER SIDE EFFECT OF THERAPEUTIC GASTRIC FREEZING.

BARNER HB, JONES TI, GARLICK TB.

JAMA. 1964 Nov 23;190:779-81. No abstract available.

PMID:
14201604
31.

Evaluation of thrombectomy in the management of iliofemoral venous thrombosis.

DEWEESE JA, JONES TI, LYON J, DALE WA.

Surgery. 1960 Jan;47:140-59. No abstract available.

PMID:
13816313
32.

The beneficial effects of coronary perfusion on the hypothermic myocardium during caval occlusion.

DEWEESE JA, JONES TI, McCOORD A, MAHONEY EB.

Surgery. 1959 Oct;46:733-46. No abstract available.

PMID:
13816314
33.
34.

Pulse transmission through grafts.

NIGUIDULA FN, JONES TI, DALE WA.

Surg Gynecol Obstet. 1959 Jan;108(1):61-4. No abstract available.

PMID:
13625046
35.

Coronary artery perfusion with oxygenated whole blood in open cardiac surgery under hypothermia.

MAHONEY EB, DE WEESE JA, JONES TI, MANNING JA.

Bull Soc Int Chir. 1958 Mar;17(1):34-40. No abstract available.

PMID:
13573105
36.

Study of peripheral autogenous vein grafts.

JONES TI, DALE WA.

AMA Arch Surg. 1958 Feb;76(2):294-306; discussion 306-9. No abstract available.

PMID:
13497427
37.

Myocardial metabolism during hypothermia with caval occlusion and low flow coronary perfusion.

DEWEESE JA, JONES TI, MAHONEY EB.

Surg Forum. 1957;8:298-302. No abstract available.

PMID:
13529612

Supplemental Content

Loading ...
Support Center